CAR T cell off-target screening discussed at European CAR T Congress

Preparing cell media for Retrogenix receptor identification screen

Dr Mark Aspinall-O’Dea has presented strategies for specificity screening of CAR T cell therapies at a focused meeting of specialists working in the field. The Combined CAR T Congress Europe, held in Berlin, brought together scientists from both academia and industry in order to discuss the recent progress and challenges with CAR T development  and translation to the clinic.

Mark’s talk described the role of cell microarray technology in off-target identification using case examples to highlight key data and the contribution this can make to preparations for regulatory submissions.

To find out more details about our work on CAR T cell screening please read our case study.

CAR T case study